Mr Sankaranarayanan, CEO, Eppendorf India Ltd
After 10 successful years in India, Eppendorf India Ltd, is now exploring opportunities in the healthcare research sector. It is setting up a new state-of-the-art laboratory and service center in Chennai, which it believes will further strengthen its services and products.
Mr Sankaranarayanan, CEO, Eppendorf India Ltd, outlines that the company's key strategy is to offer premium products with best of quality and features.
Q: Eppendorf completes 10 years in India. What was the market scenario for Eppendorf back then and how is it looking now?
Mr Sankaranarayanan: The lifesciences market has grown leaps and bounds in the last 10 years. There were few ups and downs due to economic situations, but overall the market has been growing very well.
Q: How is Eppendorf geared up in handling economic instability?
I would term it as "slow-down" rather than "instability". We are very optimistic about the Indian market and we hope that the market will be back to the earlier growth rates shortly.
Such slowdowns are not very new and we are working closely with our customers and partners to improve our sales in the market.
Q: What are some of your new focus areas?
We are exploring more opportunities in the health research areas as the government is planning to invest in this segment.
We are also increasing our marketing activities to reach new customers including exploring new applicational fields for our products such as bio-processing.
Q: Elaborate on your major investments for 2014-15?
We are building a new corporate office and warehouse in Chennai. The new facility will also have a state-of the-art laboratory and service center.
We will further strengthen our technical service with more accreditation and innovative service products.
Q: Have you signed up for new partnerships and collaborations nationally and internationally?
As Eppendorf is launching several new products, we are currently focused on taking the new products effectively into the markets.